Pure autonomic failure

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:441G90.8
Who is this for?
Show terms as
2FDA treatments1Active trials37Specialists8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Pure autonomic failure (PAF), also known as Bradbury-Eggleston syndrome or idiopathic orthostatic hypotension, is a rare neurodegenerative disorder of the autonomic nervous system. It is classified as a synucleinopathy, characterized by abnormal accumulation of alpha-synuclein in peripheral autonomic neurons. PAF primarily affects the autonomic (involuntary) nervous system, which controls functions such as blood pressure regulation, heart rate, bladder function, sweating, and gastrointestinal motility. Unlike other synucleinopathies such as multiple system atrophy or Parkinson disease with autonomic failure, PAF does not involve significant central nervous system degeneration, at least in its early stages. The hallmark symptom of PAF is severe orthostatic hypotension — a dramatic drop in blood pressure upon standing — which leads to dizziness, lightheadedness, blurred vision, and fainting (syncope). Other common symptoms include urinary dysfunction (urinary frequency, urgency, or retention), constipation, reduced sweating (anhidrosis or hypohidrosis), erectile dysfunction in men, and supine hypertension (elevated blood pressure when lying down). Symptoms typically develop insidiously in middle to late adulthood. Notably, some patients with PAF may eventually convert (phenoconvert) to other synucleinopathies, including Parkinson disease, dementia with Lewy bodies, or multiple system atrophy, making long-term follow-up essential. There is currently no cure or disease-modifying therapy for PAF. Treatment is symptomatic and focuses primarily on managing orthostatic hypotension and other autonomic symptoms. Non-pharmacological measures include increased fluid and salt intake, wearing compression garments, and avoiding sudden postural changes. Pharmacological options include midodrine (a vasopressor), droxidopa (a norepinephrine precursor approved for neurogenic orthostatic hypotension), and fludrocortisone (a mineralocorticoid to expand blood volume). Management of supine hypertension, which often coexists with orthostatic hypotension, requires careful balancing of treatments. Patients benefit from multidisciplinary care involving neurologists, cardiologists, and urologists.

Also known as:

Clinical phenotype terms— hover any for plain English:

AnhidrosisHP:0000970Orthostatic hypotensionHP:0001278Abnormality of circulating catecholamine levelHP:0012099Constitutional symptomHP:0025142
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

10 events
Jul 2026Catheter Ablation Using a Novel Navigation and Imaging System

LUMA Vision Ltd.

TrialNOT YET RECRUITING
Jun 2026SMART-VERAPAF: Self-MAnagement and Random Therapy With VERApamil or Metoprolol in Paroxysmal Atrial Fibrillation

Martini Hospital Groningen — PHASE4

TrialNOT YET RECRUITING
Apr 2026The Effect of Pulse Field Ablation of Atrial Fibrillation Involving Posterior Wall Ablation on Atrial Mechancis Assessed by Cardiac Magnetic Resonance Imaging

Assistance Publique - Hôpitaux de Paris — NA

TrialNOT YET RECRUITING
Mar 2026Grid eXplore Mapping Study

Abbott Medical Devices — NA

TrialNOT YET RECRUITING
Mar 2026Biofeedback Intervention for Paroxysmal Atrial Fibrillation

Liverpool John Moores University — NA

TrialNOT YET RECRUITING
Feb 2026Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System

Boston Scientific Corporation — NA

TrialRECRUITING
Feb 2026P-wave Duration and Local Potential as Predictors of AF Recurrence Following Pulmonary Vein Isolation

CathVision ApS

TrialNOT YET RECRUITING
Jan 2026PREACTIVE: Preconditioning Exercise Intervention to Improve Symptoms and Quality of Life in Comorbid Atrial Fibrillation and HFpEF

Northwestern University — NA

TrialNOT YET RECRUITING
Jan 2026Comparative Efficacy of 100-, 200-, & 400-mg Amiodarone in Patients With Paroxysmal AF Depending on Plasma Concentration

Tomsk National Research Medical Center of the Russian Academy of Sciences — PHASE4

TrialENROLLING BY INVITATION
Jan 2026NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System

Pulse Biosciences, Inc. — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

NORTHERA

droxidopa· Lundbeck LLC■ Boxed Warning
indicated for the treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caus

indicated for the treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (pure autonomic failure)

Amatine

Midodrine HCl· Takeda Development Center Americas, Inc.Orphan Drug

Treatment of symptomatic orthostatic hypotension.

Clinical Trials

1 recruitingView all trials with filters →
N/A1 trial
Effect of Raised Head of the Bed on Lying Blood Pressure in Autonomic Failure
N/A
Actively Recruiting
PI: Italo Biaggioni, MD (Vanderbilt University Medical Center) · Sites: Nashville, Tennessee · Age: 1885 yrs

Specialists

Showing 25 of 37View all specialists →
AM
Alvin McElveen, MD
Specialist
PI on 1 active trial1 Pure autonomic failure publication
RM
Richard Hull, MD
Specialist
PI on 1 active trial
SM
Stephen Greer, MD
Specialist
PI on 1 active trial
BM
Brent Goodman, MD
PERIDOT, AZ
Specialist
PI on 1 active trial
AM
Alberto Vasquez, MD
Specialist
PI on 1 active trial1 Pure autonomic failure publication
SM
Saverio Iacopino, MD
Specialist
PI on 2 active trials
MS
Mikhail Samsonov
Specialist
PI on 17 active trials
HM
Horacio Kaufmann, MD
NEW YORK, NY
Specialist
PI on 10 active trials
AM
Andrea Natale, MD
AUSTIN, TX
Specialist
PI on 6 active trials1 Pure autonomic failure publication
IM
Italo Biaggioni, MD
NASHVILLE, TN
Specialist
PI on 24 active trials
DM
David Robertson, MD
Specialist
PI on 3 active trials
MM
Meredith Hawkins, M.D., M.S.
PRUNEDALE, CA
Specialist
PI on 4 active trials
TM
Todd Levine, MD
Specialist
PI on 2 active trials
IM
Italo Biaggioni, M.D.
NASHVILLE, TN
Specialist
PI on 4 active trials
LM
Luis Okamoto, MD
Specialist
PI on 2 active trials1 Pure autonomic failure publication
MP
Mauricio I Scanavacca, MD, PhD
Specialist
PI on 3 active trials
EM
Ehud Chorin, MD
NEW YORK, NY
Specialist
PI on 2 active trials
JM
Jocelyne Bloch, MD
Specialist
PI on 5 active trials
AM
Andrea Maier
Aachen, North Rhine-Westphalia
Specialist

Rare Disease Specialist

PI on 1 active trial10 Pure autonomic failure publications
KM
Khaldoun Tarakji, MD
Tampa, Florida
Specialist

Rare Disease Specialist

PI on 6 active trials
CM
Cyndya A Shibao, MD
NASHVILLE, TN
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Amatine(Midodrine HCl)Takeda Development Center Americas, Inc.

Travel Grants

No travel grants are currently matched to Pure autonomic failure.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Pure autonomic failureForum →

No community posts yet. Be the first to share your experience with Pure autonomic failure.

Start the conversation →

Latest news about Pure autonomic failure

Disease timeline:

New recruiting trial: EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: The Impact of Expandable Cryoballoon on Autonomic Control of the Heart

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: STOP AF First Post-Approval Study

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: Safety and Efficacy of the CoolCryo System for Cardiac Cryoablation in the Treatment of Atrial Fibrillation

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: Evaluation of the Impact of Pulsed Field Ablation on Autonomic Nervous System Modulation in Paroxysmal Atrial Fibrillation

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: Quantitative Superior Vena Cava Isolation in Addition to Pulmonary Vein Isolation for Paroxysmal Atrial Fibrillation

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: Pulsed Field Ablation With Concomitant Radiofrequency Cardioneuroablation in Patients With Paroxysmal Atrial Fibrillation

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: Clinical Usefulness of Virtual Ablation Guided Catheter Ablation of Atrial Fibrillation: Virtual Rotor Mapping and Catheter Ablation

A new clinical trial is recruiting patients for Pure autonomic failure

New recruiting trial: LA Function After PFA in Paroxysmal AF

A new clinical trial is recruiting patients for Pure autonomic failure

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Pure autonomic failure

What is Pure autonomic failure?

Pure autonomic failure (PAF), also known as Bradbury-Eggleston syndrome or idiopathic orthostatic hypotension, is a rare neurodegenerative disorder of the autonomic nervous system. It is classified as a synucleinopathy, characterized by abnormal accumulation of alpha-synuclein in peripheral autonomic neurons. PAF primarily affects the autonomic (involuntary) nervous system, which controls functions such as blood pressure regulation, heart rate, bladder function, sweating, and gastrointestinal motility. Unlike other synucleinopathies such as multiple system atrophy or Parkinson disease with aut

How is Pure autonomic failure inherited?

Pure autonomic failure follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Pure autonomic failure typically begin?

Typical onset of Pure autonomic failure is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Pure autonomic failure?

Yes — 1 recruiting clinical trial is currently listed for Pure autonomic failure on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Pure autonomic failure?

25 specialists and care centers treating Pure autonomic failure are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Pure autonomic failure?

1 patient support program are currently tracked on UniteRare for Pure autonomic failure. See the treatments and support programs sections for copay assistance, eligibility, and contact details.